Chronic Graft-versus-Host Disease: Understanding the Disease and Its Widespread Symptoms

Opinion
Video

Panelists discuss how chronic graft-versus-host disease (cGVHD) differs from acute GVHD, its main challenges for patients, and its common symptoms and impact on daily life.

  • Can you provide some background on cGVHD? How does it differ from acute GVHD, and what are the main challenges it presents for patients?
  • From your experience, what are the most common symptoms you see in cGVHD patients, and how do these symptoms impact their daily lives?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
4 experts in this video
4 experts in this video
Photo of a man wearing glasses and a suit in front of a blue background
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

Leana Cabrera Chien and William Dale Underscore The Value of Geriatric Assessments in Optimizing Cancer Care

Leana Cabrera Chien and William Dale Underscore The Value of Geriatric Assessments in Optimizing Cancer Care

Lindsay Fischer
August 4th 2023
Podcast

Leana Cabrera Chien, MSN, RN, GCNS-BC, GNP-BC, and William Dale, MD, PhD, discuss why geriatric assessments are important in providing individualized care.

Photo of a patient holding a prescription bottle of pills and speaking with a doctor holding a clipboard

Pacritinib Shows Preliminary ORR in Chronic Graft-Vs-Host Disease

Kristi Rosa
April 9th 2025
Article

Pacritinib showed early activity and was safe for patients with multi-refractory chronic graft-vs-host disease.

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Lindsay Fischer
March 15th 2023
Podcast

In this episode of The Vitals, Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses the treatment journey of a patient who required multiple lines of therapy for ALL.

diverse hands being raised

How to Overcome 4 Common Barriers to Cancer Clinical Trial Access

Brielle Benyon
November 7th 2024
Article

An oncology nurse discusses 4 common barriers certain patient populations face when it comes to oncology clinical trials, and what clinicians can do to mitigate these disparities.

FDA Approves Axatilimab for Chronic Graft-vs-Host Disease

FDA Approves Axatilimab for Chronic Graft-vs-Host Disease

Darlene Dobkowski, MA
August 14th 2024
Article

The FDA approved axatilimab for adults and children with chronic graft-vs-host disease whose disease progressed after 2 or more lines of systemic therapy.